# Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%

> **NCT05264558** · PHASE4 · COMPLETED · sponsor: **Macfarlane Burnet Institute for Medical Research and Public Health Ltd** · enrollment: 606 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DEVICE:** Xpert HCV Viral load finger stick point of care test (Cepheid)
- **DRUG:** Epclusa 400Mg-100Mg Tablet
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT05264558
- **Lead sponsor:** Macfarlane Burnet Institute for Medical Research and Public Health Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-25
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 606 (ACTUAL)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264558, "Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05264558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*